Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial Multiple myeloma (MM) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results